BML is mainly engaged in the provision of laboratory testing services including endocrine, plasma protein, biochemical, viral, immunological, hematological, bacteriological and histopathological tests as well as related services. Co.'s services include laboratory testing, "Frontier" and "Synphony" systems, and preventive medicine; electronic medical chart systems; food sanitation tests, safety assessment of genetically modified organisms, environment analysis, analysis of residual agricultural chemicals, dental tests, CRO, SMO, and clinical trials; and utilization of technology and information derived from the human genome study to provide gene analysis that is used in medical treatment.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.